This article was originally published on PharmaTimes http://www.pharmatimes.com/news/uks_enterprise_therapeutics_raises_29m_1231511

Brighton, UK-based Enterprise Therapeutics has raised £29 million to help it advance its experimental therapies for respiratory diseases.

Related Posts